HK Stock MarketDetailed Quotes
06826 HAOHAI BIOTEC
- 42.000
- +1.100+2.69%
Market Closed May 2 16:08 CST
7.09BMarket Cap14.85P/E (TTM)
42.000High40.450Low38.70KVolume40.900Open40.900Pre Close1.61MTurnover0.13%Turnover Ratio15.43P/E (Static)168.71MShares50.20052wk High1.12P/B1.24BFloat Cap29.85952wk Low0.45Dividend TTM29.60MShs Float148.133Historical High0.448Dividend LFY3.79%Amplitude19.959Historical Low41.597Avg Price100Lot Size1.07%Div YieldTTM1.07%Div Yield LFY
HAOHAI BIOTEC Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 115.61%508.26M | ---- | ---- | ---- | -38.40%235.73M | ---- | ---- | ---- | 48.88%382.65M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 11.53%-77.99M | ---- | ---- | ---- | 10.73%-88.16M | ---- | ---- | ---- | 9.67%-98.76M |
| Dividend (income)- adjustment | ---- | 37.61%-423K | ---- | ---- | ---- | 98.82%-678K | ---- | ---- | ---- | -59.35%-57.54M |
| Attributable subsidiary (profit) loss | ---- | 86.99%-456K | ---- | ---- | ---- | -59.83%-3.51M | ---- | ---- | ---- | -1,774.05%-2.19M |
| Impairment and provisions: | --0 | -93.16%4.77M | --0 | --0 | --0 | 1,902.92%69.76M | --0 | --0 | --0 | -248.75%-3.87M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --6.94M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | -17.47%6.74M | ---- | ---- | ---- | 1,288.94%8.17M | ---- | ---- | ---- | -117.30%-687K |
| -Impairment of trade receivables (reversal) | ---- | -112.72%-1.97M | ---- | ---- | ---- | 587.62%15.52M | ---- | ---- | ---- | -132.43%-3.18M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | --9.57M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | --29.56M | ---- | ---- | ---- | ---- |
| Revaluation surplus: | --0 | -129.50%-2.3M | --0 | --0 | --0 | 32,533.33%7.78M | --0 | --0 | --0 | ---24K |
| -Other fair value changes | ---- | -129.50%-2.3M | ---- | ---- | ---- | 32,533.33%7.78M | ---- | ---- | ---- | ---24K |
| Asset sale loss (gain): | --0 | -216.57%-591K | --0 | --0 | --0 | 35.92%507K | --0 | --0 | --0 | -66.15%373K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | --90K | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -241.73%-591K | ---- | ---- | ---- | 11.80%417K | ---- | ---- | ---- | -66.15%373K |
| Depreciation and amortization: | --0 | -3.12%197.86M | --0 | --0 | --0 | 25.41%204.22M | --0 | --0 | --0 | 22.55%162.84M |
| -Depreciation | ---- | 1.91%136.95M | ---- | ---- | ---- | 15.22%134.37M | ---- | ---- | ---- | 18.98%116.62M |
| -Amortization of intangible assets | ---- | -12.79%60.91M | ---- | ---- | ---- | 51.12%69.84M | ---- | ---- | ---- | 32.60%46.22M |
| Financial expense | ---- | -4.05%7.3M | ---- | ---- | ---- | 53.19%7.6M | ---- | ---- | ---- | 1.18%4.96M |
| Unrealized exchange loss (gain) | ---- | 109.17%5.61M | ---- | ---- | ---- | -30.74%2.68M | ---- | ---- | ---- | 24.44%3.88M |
| Special items | ---- | -67.15%7.42M | ---- | ---- | ---- | 703.34%22.58M | ---- | ---- | ---- | -89.95%-3.74M |
| Operating profit before the change of operating capital | --0 | 41.64%649.45M | --0 | --0 | --0 | 18.00%458.51M | --0 | --0 | --0 | 52.77%388.57M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 65.13%-48.42M | ---- | ---- | ---- | -385.06%-138.86M | ---- | ---- | ---- | -53.20%-28.63M |
| Accounts receivable (increase)decrease | ---- | 119.36%10.13M | ---- | ---- | ---- | -24.82%-52.33M | ---- | ---- | ---- | -368.07%-41.92M |
| Accounts payable increase (decrease) | ---- | 4,840.29%103.01M | ---- | ---- | ---- | -97.61%2.09M | ---- | ---- | ---- | 28.31%87.18M |
| prepayments (increase)decrease | ---- | -20.47%5.93M | ---- | ---- | ---- | 2.84%7.45M | ---- | ---- | ---- | 143.06%7.25M |
| Cash from business operations | --0 | 162.76%722.64M | --0 | 149.90%325.04M | --0 | -33.33%275.02M | --0 | -16.12%130.07M | --0 | 28.40%412.5M |
| Other taxs | ---- | -101.70%-88.19M | ---- | -168.36%-41.07M | ---- | 37.73%-43.72M | ---- | 55.34%-15.3M | ---- | -18.64%-70.22M |
| Special items of business | ---- | 238.06%2.54M | ---- | ---- | ---- | -3,575.47%-1.84M | ---- | ---- | ---- | 105.50%53K |
| Net cash from operations | -4.96%75.97M | 174.30%634.45M | 116.37%391.56M | 147.44%283.97M | 1,687.78%79.93M | -32.43%231.3M | 0.18%180.97M | -4.99%114.76M | -71.36%4.47M | 30.61%342.29M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -11.54%77.99M | ---- | -7.54%38.62M | ---- | -8.98%88.16M | ---- | -17.43%41.77M | ---- | -11.40%96.87M |
| Dividend received - investment | ---- | -37.61%423K | ---- | -38.30%290K | ---- | -98.82%678K | ---- | -98.21%470K | ---- | 59.35%57.54M |
| Decrease in deposits (increase) | ---- | 48.54%-188.16M | ---- | 5.60%-194.21M | ---- | -347.34%-365.62M | ---- | 73.23%-205.72M | ---- | -71.20%147.82M |
| Sale of fixed assets | --165.37K | 371.79%1.84M | 1,220.23%733.47K | 1,316.28%609K | ---- | 83.10%390K | 6.31%55.56K | 86.96%43K | 1,397.88%151.29K | -59.35%213K |
| Purchase of fixed assets | -420.39%-153.7M | 14.10%-265.6M | -15.06%-198.27M | 7.57%-106.02M | 16.79%-29.54M | -14.15%-309.21M | -8.85%-172.32M | -6.63%-114.71M | 11.27%-35.5M | -42.80%-270.88M |
| Purchase of intangible assets | ---- | 79.51%-1.63M | ---- | 92.68%-499K | ---- | -553.04%-7.94M | ---- | -1,251.98%-6.81M | ---- | 80.27%-1.22M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --17.59M | --17.59M | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | 93.92%-2.94M | 94.21%-2.94M | 23.36%-8.33M | ---2.94M | -13.49%-48.28M |
| Recovery of cash from investments | 260.57%1.11B | 60.62%14.57M | 13.62%1.06B | 60.64%46.52M | 511.25%306.61M | -98.49%9.07M | -28.09%931.37M | 91.22%28.96M | 47.87%50.16M | 342.24%601.46M |
| Cash on investment | -453.01%-827.26M | 90.15%-16.08M | 1.10%-1.29B | 41.76%-55.52M | 25.94%-149.59M | 77.70%-163.16M | -16.61%-1.3B | 27.13%-95.33M | 71.73%-201.98M | -128.82%-731.61M |
| Other items in the investment business | 20.40%34.56M | ---- | -25.97%30.47M | -58.62%14.57M | 82.96%28.71M | --51.17M | -63.57%41.16M | -71.79%35.2M | 368.59%15.69M | ---- |
| Net cash from investment operations | 1.99%159.29M | 44.76%-376.65M | 18.55%-397.82M | 21.21%-255.64M | 189.55%156.18M | -360.41%-681.82M | -699.43%-488.45M | 59.51%-324.46M | 75.68%-174.41M | -146.73%-148.09M |
| Net cash before financing | -0.36%235.26M | 157.22%257.8M | 97.96%-6.26M | 113.51%28.33M | 238.94%236.11M | -331.99%-450.52M | -217.30%-307.48M | 69.19%-209.7M | 75.78%-169.94M | -66.46%194.2M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -67.48%30M | 376.00%313.89M | 621.79%222.72M | 455.74%132.26M | --92.25M | 73.49%65.94M | -18.85%30.86M | 58.75%23.8M | ---- | -66.65%38.01M |
| Refund | -129.01%-12.15M | 65.80%-16.39M | 65.38%-10.62M | 80.69%-9.77M | 83.93%-5.31M | 49.85%-47.91M | 67.42%-30.67M | 10.23%-50.61M | -147.11%-33.03M | -91.50%-95.54M |
| Issuing shares | ---- | --73.68M | ---- | --55.91M | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | -2.06%-5.1M | ---- | -131.36%-1.99M | ---- | -66.40%-4.99M | ---- | -39.77%-861K | ---- | 8.26%-3M |
| Dividends paid - financing | 8.85%-2.97M | 37.02%-83.57M | 36.15%-84.42M | 61.53%-2.04M | 57.79%-3.26M | -28.94%-132.69M | -47.82%-132.21M | ---5.3M | -836.90%-7.71M | 22.28%-102.91M |
| Absorb investment income | 16.73%54.86M | 6,076.08%47M | 791.36%106.96M | 291.67%47M | 291.67%47M | -84.78%761K | 200.00%12M | 500.00%12M | 1,100.00%12M | --5M |
| Issuance expenses and redemption of securities expenses | ---- | -82.82%-269.98M | ---- | 70.77%-21.52M | ---- | -228.83%-147.67M | ---- | -63.96%-73.63M | ---- | 12.72%-44.91M |
| Other items of the financing business | 81.79%-27.61M | -1,356.20%-317.28M | -119.20%-392.53M | -1,974.65%-152.22M | -63.31%-151.63M | 21.92%-21.79M | -202.20%-179.08M | -117.14%-7.34M | -2,619.84%-92.85M | 58.37%-27.9M |
| Net cash from financing operations | 301.27%42.14M | 10.62%-257.73M | 47.21%-157.89M | 146.72%47.62M | 82.78%-20.94M | -24.69%-288.35M | -48.95%-299.1M | -142.17%-101.94M | -8,729.39%-121.58M | -21.67%-231.25M |
| Effect of rate | 75.67%-524.41K | -29.10%10.05M | 102.80%11.31M | 1,599.07%16.52M | 45.64%-2.16M | 304.25%14.17M | 391.97%5.58M | 182.16%972K | -317.09%-3.97M | -25.00%-6.94M |
| Net Cash | 29.97%276.87M | 100.01%73K | 74.57%-152.83M | 124.37%75.95M | 172.09%213.02M | -1,893.98%-738.87M | -1,111.62%-601M | 56.88%-311.64M | 57.86%-295.49M | -109.53%-37.06M |
| Begining period cash | 1.81%569.32M | -56.45%559.2M | -56.45%559.2M | -56.45%559.2M | -56.45%559.2M | -3.31%1.28B | -3.31%1.28B | -3.31%1.28B | -3.31%1.28B | 40.59%1.33B |
| Cash at the end | 9.58%846.19M | 1.81%569.32M | -40.49%406.36M | -33.04%651.67M | -21.87%772.22M | -56.45%559.2M | -50.78%682.89M | 61.13%973.23M | 57.73%988.4M | -3.31%1.28B |
| Cash balance analysis | ||||||||||
| Bank deposits | ---- | ---- | ---- | -19.44%-2.18B | ---- | ---- | ---- | 28.01%-1.82B | ---- | ---- |
| Cash and cash equivalent balance | --0 | --0 | --0 | -19.44%-2.18B | --0 | --0 | --0 | 28.01%-1.82B | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg